{"data":{"id":"us-al/ala.-code-22-5d-3","jurisdiction":"us-al","citation":"Ala. Code § 22-5D-3","heading":"Availability to Eligible Patient of Investigational Drug, Biological Product, or Device.","body":"(a) The manufacturer of an investigational drug, biological product, or device may make available and an eligible patient may request the manufacturer’s investigational drug, biological product, or device under this chapter. This chapter does not require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient.\n(b) A manufacturer may do all of the following:\n(1) Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation.\n(2) Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.","path":["Title 22 Health, Mental Health, and Environmental Control.","Title 1 Health and Environmental Control Generally.","Chapter 5D Gabe Griffin Right to Try Act."],"source_url":"https://alison.legislature.state.al.us/code-of-alabama?section=22-5D-3","current_through":"Act 2026-611","vintage":"","retrieved_at":"2026-09-03T14:01:53Z","sha256":"1b1ab760b64c00edb41d3387f40a8fc713f250f27db97088ea3044660af71b7a","source_id":"us-al","stale":false,"prev":"us-al/ala.-code-22-5d-2","next":"us-al/ala.-code-22-5d-4"},"notice":"GroundRules: Original legal text. Not legal advice."}